Phase I Clinical Trial Investigating the Effects of Caffeine Citrate on Serum Vascular Adhesion Protein -1 (VAP-1) Levels in Healthy Volunteers.
Status: Withdrawn prior to enrolment
Phase of Trial: Phase I
Latest Information Update: 19 Apr 2018
Price : $35 *
At a glance
- Drugs Caffeine citrate (Primary)
- Indications Liver cancer; Liver disorders
- Focus Pharmacodynamics
- Acronyms NOCTUA
- 31 Aug 2018 Biomarkers information updated
- 19 Apr 2018 New trial record
- 17 Apr 2018 Status changed from not yet recruiting to withdrawn prior to enrolment due to to local resource issue (never actually started post ethics approval).